Prevalence of heart failure pharmacotherapy utilisation, frailty and adverse drug events among hospitalised adults older than 75 years: a multicentre cross‐sectional study
Frailty, HF-pharmacotherapy changes in hospital and ADEs were common among older inpatients with HF. The association of adverse outcomes according to frailty needs further investigation. Poor documentation of HF phenotype may be a barrier to medication optimisation in older inpatients.
Authors
- Sarah Nicole Hilmer (ORCID: https://orcid.org/0000-0002-5970-1501)
- Danijela Gnjidic (ORCID: https://orcid.org/0000-0002-9404-3401)
- Andrew J. McLachlan (ORCID: https://orcid.org/0000-0003-4674-0242)
- David G. Le Couteur (ORCID: https://orcid.org/0000-0002-4227-5817)
- Mai H. Duong (ORCID: https://orcid.org/0000-0002-6764-3233)
- Fiona Blyth (ORCID: https://orcid.org/0000-0003-1128-6756)
- Alexandra Bennett (ORCID: https://orcid.org/0000-0002-9900-5316)
- Kevin Winardi (ORCID: https://orcid.org/0009-0007-7787-8208)
Institutions
- The University of Sydney (AU)
- Northern Sydney Local Health District (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1111/imj.16612
- Citations
- 4
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.38
Funders
- University of Sydney
- Medical Research Council
- National Health and Medical Research Council
- Faculty of Medicine and Health, University of Sydney